Skip to main content
. 2018 Jun 26;10:1749–1761. doi: 10.2147/CMAR.S160452

Figure 2.

Figure 2

ROC analyses of immune molecules and CA15-3 to distinguish BC (N = 91) from BBD (N = 31).

Notes: Differential diagnostic value of (A) PD-1, (B) CTLA-4, (C) FOXP3, (D) TGF-β, (E) IL-10, (F) IL-2Rα, (G) CD28, and (H) CA15-3.

Abbreviations: ROC, receiver-operating characteristic; CA15-3, cancer antigen 15-3; BC, breast cancer; BBD, breast benign disease; PD-1, programmed cell death 1; CTLA-4, cytotoxic T lymphocyte antigen 4; FOXP3, forkhead box P3; TGF-β, transforming growth factor-beta; IL-10, interleukin-10; IL-2Rα, interleukin-2 receptor alpha; CD28, cluster of differentiation 28; AUC, area under curve.